Rita J Desai

Array ( [id] => 1158098 [patent_doc_number] => 06762305 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-13 [patent_title] => 'Herbicidally active pyridine sulfonyl urea derivatives' [patent_app_type] => B2 [patent_app_number] => 10/731488 [patent_app_country] => US [patent_app_date] => 2003-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3712 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/762/06762305.pdf [firstpage_image] =>[orig_patent_app_number] => 10731488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7083866 [patent_doc_number] => 20050049246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Inhibitors of Src and Lck protein kinases' [patent_app_type] => utility [patent_app_number] => 10/728113 [patent_app_country] => US [patent_app_date] => 2003-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11930 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20050049246.pdf [firstpage_image] =>[orig_patent_app_number] => 10728113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5614584 [patent_doc_number] => 20060116512 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-01 [patent_title] => 'Quinolines and nitrogenated derivatives thereof and their use as antibacterial agents' [patent_app_type] => utility [patent_app_number] => 10/537034 [patent_app_country] => US [patent_app_date] => 2003-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15932 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0116/20060116512.pdf [firstpage_image] =>[orig_patent_app_number] => 10537034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7674616 [patent_doc_number] => 20040127502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Use of GAL3 antagonist for treatment of depression' [patent_app_type] => new [patent_app_number] => 10/723961 [patent_app_country] => US [patent_app_date] => 2003-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 110259 [patent_no_of_claims] => 255 [patent_no_of_ind_claims] => 34 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20040127502.pdf [firstpage_image] =>[orig_patent_app_number] => 10723961 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7411346 [patent_doc_number] => 20040106594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-03 [patent_title] => 'Phenyl heterocyclyl ethers' [patent_app_type] => new [patent_app_number] => 10/723478 [patent_app_country] => US [patent_app_date] => 2003-11-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31091 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20040106594.pdf [firstpage_image] =>[orig_patent_app_number] => 10723478 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469507 [patent_doc_number] => 20040102449 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => 'Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers' [patent_app_type] => new [patent_app_number] => 10/719538 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13547 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102449.pdf [firstpage_image] =>[orig_patent_app_number] => 10719538 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5705776 [patent_doc_number] => 20060194824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Compositions containing pyrimidine derivatives as inhibitors of cox-2' [patent_app_type] => utility [patent_app_number] => 10/535806 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6386 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194824.pdf [firstpage_image] =>[orig_patent_app_number] => 10535806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6940010 [patent_doc_number] => 20050113573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Nitroso compounds to treat ischemia' [patent_app_type] => utility [patent_app_number] => 10/719621 [patent_app_country] => US [patent_app_date] => 2003-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6055 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113573.pdf [firstpage_image] =>[orig_patent_app_number] => 10719621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588239 [patent_doc_number] => 07439250 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Compositions and methods related to fatty amino acid derivatives' [patent_app_type] => utility [patent_app_number] => 10/715331 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8140 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439250.pdf [firstpage_image] =>[orig_patent_app_number] => 10715331 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 250884 [patent_doc_number] => 07582640 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-01 [patent_title] => 'Vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same' [patent_app_type] => utility [patent_app_number] => 10/536028 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37884 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/582/07582640.pdf [firstpage_image] =>[orig_patent_app_number] => 10536028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 580676 [patent_doc_number] => 07452896 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-18 [patent_title] => 'Pyrimidine-sulfamides and their use as endothelian receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/537400 [patent_app_country] => US [patent_app_date] => 2003-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7758 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/452/07452896.pdf [firstpage_image] =>[orig_patent_app_number] => 10537400 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7676931 [patent_doc_number] => 20040152895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Sulfonamides' [patent_app_type] => new [patent_app_number] => 10/477066 [patent_app_country] => US [patent_app_date] => 2003-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4262 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152895.pdf [firstpage_image] =>[orig_patent_app_number] => 10477066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7469609 [patent_doc_number] => 20040102457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-27 [patent_title] => '4-Imidazol-1-ylmethyl pyrimidine derivatives' [patent_app_type] => new [patent_app_number] => 10/702629 [patent_app_country] => US [patent_app_date] => 2003-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20411 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0102/20040102457.pdf [firstpage_image] =>[orig_patent_app_number] => 10702629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7310555 [patent_doc_number] => 20040142930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Cyclic compounds' [patent_app_type] => new [patent_app_number] => 10/699804 [patent_app_country] => US [patent_app_date] => 2003-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44906 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142930.pdf [firstpage_image] =>[orig_patent_app_number] => 10699804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7239287 [patent_doc_number] => 20040157866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Amide compounds' [patent_app_type] => new [patent_app_number] => 10/476386 [patent_app_country] => US [patent_app_date] => 2003-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 68263 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157866.pdf [firstpage_image] =>[orig_patent_app_number] => 10476386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 606496 [patent_doc_number] => 07153861 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-26 [patent_title] => '5,6 -Trimethylenepyrimidin-4-one compounds' [patent_app_type] => utility [patent_app_number] => 10/694561 [patent_app_country] => US [patent_app_date] => 2003-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16103 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/153/07153861.pdf [firstpage_image] =>[orig_patent_app_number] => 10694561 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7468170 [patent_doc_number] => 20040053915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Use of stimulators of soluble guanylate cyclase for treating osteoporosis' [patent_app_type] => new [patent_app_number] => 10/415708 [patent_app_country] => US [patent_app_date] => 2003-10-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2324 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053915.pdf [firstpage_image] =>[orig_patent_app_number] => 10415708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7207298 [patent_doc_number] => 20040087581 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-06 [patent_title] => 'Heterocyclylalkylamines as muscarinic receptor antagonists' [patent_app_type] => new [patent_app_number] => 10/685124 [patent_app_country] => US [patent_app_date] => 2003-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27939 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20040087581.pdf [firstpage_image] =>[orig_patent_app_number] => 10685124 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5748439 [patent_doc_number] => 20060111371 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-25 [patent_title] => 'Protein tyrosine kinase inhibitors' [patent_app_type] => utility [patent_app_number] => 10/531107 [patent_app_country] => US [patent_app_date] => 2003-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7491 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20060111371.pdf [firstpage_image] =>[orig_patent_app_number] => 10531107 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7216502 [patent_doc_number] => 20050054643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Substituted polycyclic aryl and heteroaryl pyrimidinones useful for selective inhibition of the coagulation cascade' [patent_app_type] => utility [patent_app_number] => 10/680873 [patent_app_country] => US [patent_app_date] => 2003-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52234 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054643.pdf [firstpage_image] =>[orig_patent_app_number] => 10680873 [rel_patent_id] =>[rel_patent_doc_number] =>)